166 related articles for article (PubMed ID: 37623081)
1. Development of Soft Luliconazole Invasomes Gel for Effective Transdermal Delivery: Optimization to In-Vivo Antifungal Activity.
Kumari S; Alsaidan OA; Mohanty D; Zafar A; Das S; Gupta JK; Khalid M
Gels; 2023 Aug; 9(8):. PubMed ID: 37623081
[TBL] [Abstract][Full Text] [Related]
2. Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine.
Dave V; Bhardwaj N; Gupta N; Tak K
3 Biotech; 2020 Mar; 10(3):97. PubMed ID: 32099738
[TBL] [Abstract][Full Text] [Related]
3. Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of
Singh G; Narang RK
Assay Drug Dev Technol; 2024 Jan; 22(1):1-17. PubMed ID: 38156818
[TBL] [Abstract][Full Text] [Related]
4. Niosomes gel of apigenin to improve the topical delivery: development, optimization,
Alsaidan OA; Zafar A; Al-Ruwaili RH; Yasir M; Alzarea SI; Alsaidan AA; Singh L; Khalid M
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):604-617. PubMed ID: 37910394
[TBL] [Abstract][Full Text] [Related]
5. Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design its Skin Distribution Studies, Dermatokinetic Modeling & In-Vitro and Ex-Vivo Correlation.
Bhargav E; Reddy YP; Koteshwara KB
Curr Drug Deliv; 2021; 18(7):1041-1053. PubMed ID: 33319682
[TBL] [Abstract][Full Text] [Related]
6. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system.
Garg AK; Maddiboyina B; Alqarni MHS; Alam A; Aldawsari HM; Rawat P; Singh S; Kesharwani P
J Biomater Sci Polym Ed; 2021 Jun; 32(8):1009-1023. PubMed ID: 33704008
[TBL] [Abstract][Full Text] [Related]
7. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
Kaur M; Singh K; Jain SK
J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
[TBL] [Abstract][Full Text] [Related]
8. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity.
Zafar A; Imam SS; Alruwaili NK; Yasir M; Alsaidan OA; Alshehri S; Ghoneim MM; Khalid M; Alquraini A; Alharthi SS
Gels; 2022 Feb; 8(2):. PubMed ID: 35200513
[TBL] [Abstract][Full Text] [Related]
10. Novel Luliconazole Spanlastic Nanocarriers: Development and Characterisation.
Marques SM; Chavan DU; Bhide PJ; Joshi M; Kumar L; Shirodkar RK
Curr Drug Deliv; 2023; 20(6):792-806. PubMed ID: 35578877
[TBL] [Abstract][Full Text] [Related]
11. Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia.
El-Tokhy FS; Abdel-Mottaleb MMA; El-Ghany EA; Geneidi AS
Int J Pharm; 2021 Oct; 608():121080. PubMed ID: 34506923
[TBL] [Abstract][Full Text] [Related]
12. Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment.
Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(3):171-179. PubMed ID: 30101725
[TBL] [Abstract][Full Text] [Related]
13. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.
Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M
Gels; 2022 Oct; 8(11):. PubMed ID: 36354595
[TBL] [Abstract][Full Text] [Related]
14. Novel Transethosomal Gel Containing Miconazole Nitrate; Development, Characterization, and Enhanced Antifungal Activity.
Asghar Z; Jamshaid T; Sajid-Ur-Rehman M; Jamshaid U; Gad HA
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004517
[TBL] [Abstract][Full Text] [Related]
15. Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole.
Hoda Q; Aqil M; Ahad A; Imam SS; Praveen A; Qadir A; Iqbal Z
3 Biotech; 2021 Mar; 11(3):137. PubMed ID: 33708461
[TBL] [Abstract][Full Text] [Related]
16. Linalool-Incorporated Synergistically Engineered Modified Liposomal Nanocarriers for Enhanced Transungual Delivery of Terbinafine against Onychomycosis.
Gupta I; Adin SN; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M
Materials (Basel); 2023 Jun; 16(12):. PubMed ID: 37374607
[TBL] [Abstract][Full Text] [Related]
17. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA
Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
[TBL] [Abstract][Full Text] [Related]
18. Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.
Qadri GR; Ahad A; Aqil M; Imam SS; Ali A
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):139-145. PubMed ID: 26829018
[TBL] [Abstract][Full Text] [Related]
19. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
[TBL] [Abstract][Full Text] [Related]
20. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against
Alhakamy NA; Al-Rabia MW; Md S; Sirwi A; Khayat SS; AlOtaibi SS; Hakami RA; Al Sadoun H; Eldakhakhny BM; Abdulaal WH; Aldawsari HM; Badr-Eldin SM; Elfaky MA
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34203359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
